Cargando…
GRHL2 induces liver fibrosis and intestinal mucosal barrier dysfunction in non‐alcoholic fatty liver disease via microRNA‐200 and the MAPK pathway
Non‐alcoholic fatty liver disease (NAFLD) serves as the most common subtype of liver diseases and cause of liver dysfunction, which is closely related to obesity and insulin resistance. In our study, we sought to investigate effect of transcription factor grainyhead‐like 2 (GRHL2) on NAFLD and the r...
Autores principales: | Wang, Ying, Zeng, Zishu, Guan, Lin, Ao, Ran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294114/ https://www.ncbi.nlm.nih.gov/pubmed/32324317 http://dx.doi.org/10.1111/jcmm.15212 |
Ejemplares similares
-
MicroRNA 200a inhibits liver fibrosis of schistosoma
por: Xu, Ailei, et al.
Publicado: (2021) -
Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Ramai, Daryl, et al.
Publicado: (2021) -
Complements are involved in alcoholic fatty liver disease, hepatitis and fibrosis
por: Lin, Cheng-Jie, et al.
Publicado: (2018) -
Non-alcoholic Fatty Liver Disease and Liver Fibrosis during Aging
por: Li, Yuan, et al.
Publicado: (2022) -
Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease
por: Campos-Murguía, Alejandro, et al.
Publicado: (2020)